Veracyte, Inc.
VCYT
$46.16
-$0.23-0.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.14M | -980.00K | 7.05M | 5.11M | 15.16M |
| Total Depreciation and Amortization | 5.27M | 5.49M | 5.36M | 6.25M | 5.88M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.97M | 27.87M | 8.34M | 17.36M | 9.02M |
| Change in Net Operating Assets | 6.38M | 1.23M | -15.39M | -4.20M | -91.00K |
| Cash from Operations | 44.76M | 33.61M | 5.36M | 24.52M | 29.96M |
| Capital Expenditure | -2.79M | -1.29M | -1.82M | -4.14M | -2.24M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 51.06M | 1.06M | -50.00M | -50.00M | -- |
| Cash from Investing | 48.26M | -224.00K | -51.82M | -54.14M | -2.24M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.79M | 1.81M | 2.97M | 3.26M | 12.47M |
| Repurchase of Common Stock | -2.81M | -2.38M | -9.45M | -3.27M | -2.18M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -4.50M | -- |
| Cash from Financing | 2.98M | -566.00K | -6.48M | -4.51M | 10.29M |
| Foreign Exchange rate Adjustments | 60.00K | 573.00K | 74.00K | -401.00K | 146.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 96.06M | 33.39M | -52.87M | -34.53M | 38.16M |